Search tips
Search criteria

Results 1-25 (1036248)

Clipboard (0)

Related Articles

1.  A clinical study of Panchakola Siddha Yavagu in the management of Agnimandya 
Ayu  2011;32(1):70-75.
This research is carried out with the aim to study Agnidipana effect of Panchakola Siddha Yavagu which comprises Pippali (Piper longum), Pippalimula (root of Piper longum), Chavya (Piper chaba Hunter), Chitraka (Plumbago zelynica) and Nagara (Zingiber officinale) which are all in equal proportion processed in six times of water. A randomized open clinical trial on 47 patients of Agnimandya has been screened on the basis of clinical findings and the patients were allocated to two groups. Group A having 29 cases received the trial drug (Panchakola Siddha Yavagu) and 18 cases in Group B received simple Yavagu with roasted rice powder as the control group. Special scoring pattern was done for the assessment of Agnimandya state. Complete cure of the patient was found in 17.24% of the patients, 34.48% patients were improved moderately as well as markedly, whereas mild improvement was observed in 13.80% patients by treatment with Panchakola Yavagu.
PMCID: PMC3215422  PMID: 22131761
Agnimandya; Agnidipana; Panchakola; Yavagu
2.  A clinical trial of Sri Lankan traditional decoction of Pitawakka Navaya in the treatment of Kaphaja Shirsha Shoola 
Ayu  2010;31(3):268-271.
Authentic Ayurvedic texts mention 11 types of Shiro Roga (diseases in the head). Kaphaja Shirsha Shoola, which occurs due to vitiation of Kapha and Vata Dosha, is one of them. Chronic sinusitis is a chronic inflammation of the sinuses. It can be correlated with Kaphaja Shirsha Shoola. Decoction of Pitawakka Navaya consists of nine ingredients; these are: Bhoomyamalaka, Haritaki, Barangi, Chavya, Pippali, Salarka, Guduchi, Shunthi and Maricha. These herbs, which pacify vitiated Vata Dosha and Kapha Dosha, are used by traditional physicians in Sri Lanka to treat Kaphaja Shirsha Shoola (chronic sinusitis). However, no scientific studies have been conducted to evaluate the efficacy of Pitawakka Navaya in the treatment of Kaphaja Shirsha Shoola. Hence, this clinical study was conducted to evaluate the efficacy of the decoction of Pitawakka Navaya in the treatment of Kaphaja Shirsha Shoola. Sixty patients suffering from Kaphaja Shirsha Shoola were selected and examined. These patients were randomly divided into two groups of 30 patients each. The first group was treated with 120 ml of decoction of Pitawakka Navaya twice a day for 14 days. The second group was treated with 120 ml of placebo twice a day for 14 days. After treatment, most of the patients’ symptoms were completely or partially relieved. In <10% of the patients, some symptoms were unchanged or aggravated. It is observed that the traditional decoction Pitawakka Navaya is beneficial for Kaphaja Shirsha Shoola (chronic sinusitis).
PMCID: PMC3221057  PMID: 22131725
Chronic Sinusitis; Kaphaja Shirsha Shoola; Decoction of Pitawakka Navaya
3.  A clinical trial of Sri Lankan traditional decoction of Pitawakka Navaya in treatment of Kaphaja Shirsha Shoola (chronic sinusitis) 
Ayu  2010;31(2):193-196.
Authentic Ayurvedic texts mention eleven types of Shiro Roga (diseases in head). Kaphaja Shirsha Shoola, which occurs due to vitiation of Kapha and Vata Dosha, is one of them. Chronic sinusitis is a chronic inflammation of sinuses. It can be correlated with Kaphaja Shirsha Shoola. Decoction of Pitawakka Navaya consists of nine ingredients. They are Bhoomyamalaka, Haritaki, Bharangi, Chavya, Pippali, Salarka, Guduchi, Shunti and Maricha. These herbs, which pacify vitiated Vata Dosha and Kapha Dosha, are used by traditional physicians in Sri Lanka to treat Kaphaja Shirsha Shoola (chronic sinusitis). However, no scientific studies have been conducted to evaluate the efficacy of Pitawakka Navaya in treatment of Kaphaja Shirsha Shoola. Hence, this clinical study has been conducted to evaluate its efficacy.. Sixty patients suffering from Kaphaja Shirsha Shoola were selected and examined. These patients were randomly divided into two groups of thirty patients each. First group was treated with 120 ml of decoction of Pitawakka Navaya twice a day for fourteen days. The second group was treated with 120 ml of placebo twice a day for fourteen days. After treatment, most of the patients’ symptoms were completely or partially relieved. In less than 10% of patients, some symptoms were unchanged or aggravated. It is observed that traditional decoction Pitawakka Navaya is beneficial for Kaphaja Shirsha Shoola (chronic sinusitis).
PMCID: PMC3215363  PMID: 22131709
Chronic sinusitis; decoction of Pitawakka Navaya; Kaphaja Shirsha Shoola
4.  Anti-inflammatory activity of two varieties of Pippali (Piper longum Linn.) 
Ayu  2012;33(2):307-310.
The present study has beenundertaken to evaluate the anti-inflammatory activity of two varieties of Pippali in acute and sub-acute experimental models of inflammation in albino rats. Four different market samples of each variety of Pippali were procured from different regions of India. The samples collected from South India which have given more extractive values were selected for screening of anti-inflammatory activity. Randomly selected animals were divided into four groups of six animals each. The test drugs were administered orally at a dose of 200 mg/kg and the activity was compared with standard anti-inflammatory drugs in both models. Among the two different test samples studied, it was found that Chhoti variety of Pippali suppressed inflammation of both acute and sub acute phase, while Badi variety of Pippali only of acute phase. Thus for the therapeutic utility, Chhoti variety of Pippali may be considered over the Badi variety.
PMCID: PMC3611634  PMID: 23559810
Anti-inflammatory; carrageenan; Chhoti Pippali; Pippali; plethysmograph
5.  PA01.67. Clinical study on role of Guduchyadi pippali yoga in sukra kshaya w.s.r. Oligospermia 
Ancient Science of Life  2012;32(Suppl 1):S117.
An estimated 15% couples are infertile. In this male factor is 30%, female factor is 30%, both factors are 30% and idiopathic causes are 10%. Among them shukra kshaya [oligospermia] is the major cause. Infertility severely affects the couple in their Psychological harmony, Sexual life and social activity. So the qualitative and quantitative increase in sukra is the main purpose of this study.
The study was conducted with an open trial with randomised selection. Guduchyadi pippali yoga consists of Guduchi satva, pippali churna, Ela churna, Abraka bhasma, Loha bhasma and sita and it was given in 500mg tab form mixed with honey and ksheera as anupana. This drug has been given for 45 days and patient was asked to review in every 15 days with the help of subjective parameters from the patient and objective parameters from a laboratory the results were assessed.
The results are encouraging in both subjective and objective parameters. Among 30 patients 5 patients reported that their partner got conceived.
The sperm count and sperm motility are markedly improved. No side effects have been reported. Thus it finally noticed that Ayurveda has proper answer to male infertility which is caused by oligospermia. So the purpose of this study is fulfilled.
PMCID: PMC3800871
6.  A comparative study on Vamana Karma with Madanaphala and Krutavedhana in Ekakushtha (Psoriasis) 
Ayu  2011;32(4):487-493.
Vamana Karma (therapeutic emesis) is the best therapy for the elimination of vitiated Kapha Dosha. In the present clinical practice Madanaphala (Randia dumetorum) is mainly used for Vamana Karma. Apart from Madanaphala, five other drugs, and in total 355 formulations are described in Charaka Samhita; one of them is Krutavedhana (Luffa acutangula) kalpa (formulations). Krutavedhana is specially indicated in Gadha (compact) Dosha condition like Kushtha (skin diseases), Garavisha (slow poison), and so on, for Vamana Karma. The present study aimed to observe the effect on Vamana Karma and by that its effect on Ekakushtha (Psoriasis). Krutavedhana Beeja Churna (seed powder) was given with Madhu (honey) and Saindhava (rock salt) as Vamana Yoga (emetic formulation), to compare it with Madanaphala Pippali Churna (seed powder). After the Sansarjana Krama (special dietetic schedule), Panchatikta Ghrita (medicated ghee) was given as Shamana Sneha (pacifying oleation). An average dose of Krutavedhana was 5.9 g. Krutavedhana could produce a good number of Vega (bouts), Pittanta Lakshana (bile coming out at the end of Vamana), and Pravara Shuddhi (maximum cleansing) in a majority of patients. Madanaphala is the best among all Vamaka (emetic) drugs, but Krutavedhana showed a similar to higher effect on Vamana Karma in terms of Antiki, Maniki, Vaigiki, and Laingiki Shuddhi (cleansing criteria). Vamana Karma by Krutavedhana showed better relief in Matsyashakalopamam (silvery scale), Kandu (itching), and Rukshataa (dryness), while Madanapahala showed better relief in Krishnaruna Varna (erythema). After completion of the Shamana (pacifying) treatment, both the groups showed nearly the same effect on Asvedanam (lack of perspiration), Matsyashakalopamam, Kandu, Rukshataa, Krishnaruna Varna, and Mahaavaastu (bigger lesion).
PMCID: PMC3361923  PMID: 22661842
Ekakushtha; Krutavedhana; Madanaphala; Panchatikta Ghrita; Psoriasis; Vamana Karma
7.  Clinical study of the Immunoglobululin Enhancing effect of “Bala compound” on Infants 
Ancient Science of Life  2009;28(3):18-22.
Kaumarbhritya a branch of Asthanga Ayurveda deals with neonatal, infant and child health care. Multicentric studies conducted in various developed and developing countries have indicated that Infant Mortality Rate (I.M.R.) is very high in developing countries, and infection has been observed as the major cause. Immune system in neonates is not yet fully functional. Bala compound having the ingredients of Atibala (Abutilon indicum Linn), Amalaki (Emblica officinalis Linn), Vidanga (Emblica ribes burn), Guduchi (Tinospora cordifolia Welld Miers), Pippali (Piperlongum linn), Yashtimadhu (Glycyrrhiza glabra Linn), Shankhapuspi (Convolvulus pluricaulis Chois ), Vacha (Acorus calamus Linn), Musta (Cyperus rotundus Linn) and Ativisha (Aconitum heterophyllum wall) are Medhya as well as Rasayana drugs mention in Ayurvedic classics. ‘Bala compound” was tried in infants in the form of oral drops for a period of six months and result was assessed for serum immuoglobulins IgG, IgM, IgA for three months of interval of two follow ups (i.e., third and six month of infant). There is significant increase of immunoglobulins observed after six months administration of ‘Bala compoumd”
PMCID: PMC3336317  PMID: 22557316
8.  A clinical study on Krimidanta with reference to dental caries and its management with Jatipatradi Gutika and Yavanadi Churna 
Ayu  2010;31(2):223-227.
Dental caries is progressive destruction of enamel, dentine and cementum, initiated by microbial activity at the tooth surface. It is one of the major problems in dentistry. On the basis of clinical features, it can be compared with Krimidanta which is one among the eight diseases of tooth. In the management of Krimidanta, Krimighna, Vataghna and Ushna Veerya dravyas are to be used which can relieve the toothache and discoloration. In this study, the trial drugs used were Jatipatradi Gutika for Pratisarana and Yavanadi Churna for oral administration. In this study, the patients of Krimidanta (dental caries) were selected from OPD of Shalakya Department and allotted randomly in different groups. In Group A, the patients were treated with Jatipatradi Gutika for Pratisarana for 30 days. In Group B, the patients were treated with Yavanadi Churna orally and Group C patients were treated with combined therapy for 30 days. The clinical study has shown that combined therapy gives better results than individual therapies.
PMCID: PMC3215368  PMID: 22131714
Dental caries; Jatiptradi Gutika; Krimidanta; Pratisarana; Yavanadi Churna
9.  Role of Kasahara Dashemani Vati in Kasa and Vyadhikshamatva in children with special reference to recurrent respiratory tract infections 
Ayu  2013;34(3):281-287.
The present single-centered randomized control trial (RCT) was carried out with the prime aim of assessing the effect of Kasahara Dashemani Vati (trial drug) on Kasa and Vyadhikshamatva in the children suffering from recurrent respiratory tract infections and comparing it with the efficacy of Indukanta Vati. The clinical trial included 40 patients belonging to age group of 3-12 years. The drugs were administered in a daily dose fixed as per “Clark's Rule” along with honey for duration of 60 days. The effect of treatment on the signs and symptoms of Kasa was assessed on the 15th day, whereas the effect on Vyadhikshamatva was assessed on the 60th day. The patients were under follow-up for a period of 60 days after completing the treatment course for evaluation of any recurrence. Effect of the therapy on the individual signs and symptoms of Kasa, laboratory parameters, immunoglobulin (Ig) biomarkers, status of Atura Bala, and prevention of recurrence during follow-up period were the parameters used to assess the overall effect of therapy. The observed data were subjected to appropriate statistical analysis for testing the statistical significance. Kasahara Dashemani provided relief in all symptoms of Kasa irrespective of Doshic involvement and on the parameters of Atura Bala. All the changes were statistically highly significant. The control group also showed similar effects which were statistically highly significant. The trial group was found to have a direct influence on serum Ig status. No patient has reported any adverse drug reactions during the treatment and follow-up periods.
PMCID: PMC3902595  PMID: 24501524
Immunoglobulin; Indukanta Vati; Kasahara Dashemani Vati; Recurrent respiratory tract infection; Vyadhikshamatva
10.  A clinical review of different formulations of Vasa (Adhatoda vasica) on Tamaka Shwasa (asthma) 
Ayu  2010;31(4):520-524.
Vasa (Adhatoda vasica Linn.) is a well known and easily available drug in almost all the seasons. Easy availability of any drug gains popularity among physicians as well as pharmaceuticals and this is the reason why almost every Kalpana of Vasa is found described in the Ayurvedika text. The different dosage forms of Vasa like Kvatha, Avaleha, Sneha, and Sandhana have been used for the treatment of Shwasa Roga. A number of research studies have been performed on different formulations of Vasa and its effect on Shwasa Roga. Therefore, a review study has been carried out on the Vasa extract, Vasa Avaleha (prepared from Svarasa and Kvatha), Vasa Ghrita, Vasarishta, and Vasakasava on Shwasa Roga, to know which formulation is better. It was found in the review that Vasa Ghana, Vasa Ghrita (1), and Vasa Avaleha have shown good results on Tamaka Shwasa.
PMCID: PMC3202261  PMID: 22048552
Ghana (extract); Avaleha; Shwasa; Asava; Arishta; Tamaka Shwasa; Adhatoda vasica
11.  A clinical study of Haritaki and Saindhava Lavana in Kaphaja Kasa with special reference to Samyoga Guna 
Ayu  2011;32(3):357-360.
In clinical practice, Guna which are to be with Bhisak are mainly the Paradi Gunas which can also be called as Miscellaneous Gunas. As rightly quoted by Acarya Caraka, for getting success in the treatment Paradi Gunas are the best. The Sutra quotes “Sidhyupaya Cikitsayam” which means that Cikitsa i. e. Dhatusamya will be done mainly with the help of Paradi Gunas. Thus in this study an attempt was made to know the comparative effect of Haritaki and Saindhava lavana alone and Samyukta effect in Kaphaja Kasa. Three groups were made for proper evaluation of the therapy. In Group-A Haritaki Tablet 2 gm/ twice a day (500 mg tablet × 4), In Group-B Saindava Lavana Curna 2 gm/ twice a day and in Group-C Haritaki + Saindhava lavana Tablet 4 gm/twice a day (500 mg tablet × 8) was given. Results were assessed after 7 days with the help of a specially prepared proforma. The hematological, Urine and Stool investigations were carried out. In subjective and objective criterias, significant results were found in Group-C as compared to Group-A and Group-B. Based on the results, it can be concluded that the combined (Samyoga) effect of Haritaki and Saindhava lavana is much efficient than the single drug therapy.
PMCID: PMC3326882  PMID: 22736910
Guna; Haritaki; Paradi Guna; Saindhava lavana; Samyoga
12.  A Clinical study of Matra Vasti and an ayurvedic indigenous compound drug in the management of Sandhigatavata (Osteoarthritis) 
Ayu  2010;31(2):210-217.
Sandhigatavata is described under vatavyadhi in all ayurvedic classical texts. Osteoarthritis is the most common articular disorder which begins asymptomatically in the second and third decades and is extremely common by age 70. Here Matra Vasti (therapeutic enema) was given with Bala taila as Vasti is the best treatment for vatavyadhies. It has vatashamaka and rasayana properties. Indigenous compound drug containing Guggulu, Shallaki, Yastimadhu, Pippali, Guduchi, Nirgundi, Kupilu and Godanti was given in one group along with Matra Vasti. In this study, 33 patients of Sandhigatavata completed the treatment. Patients were randomly divided into two groups. Sixteen patients in Group-A (sarvanga Abhyanga-swedana + matravasti) and 17 patients in Group-B (sarvanga Abhyanga–swedana+ matravasti + indigenous compound drug). The results of the study indicate that the patients of both the groups obtained highly significant relief in almost all the signs and symptoms of Sandhigatavata.
PMCID: PMC3215366  PMID: 22131712
Abhyanga; indigenous compound drug; Matra Vasti; osteoarthritis; Sandhigatavata; swedana; vatavyadhi; therapeutic enema.
13.  Evaluation of Anti-Secretory and Anti-Ulcerogenic Activities of Avipattikar Churna on The Peptic Ulcers in Experimental Rats 
Background: Avipattikar churna, a poly-herbal formulation, is one of the popular ayurvedic formulations which is used for peptic ulcer diseases but the scientific documentation with regards to its effect for the indication is lacking.
Aims: This study was carried out to evaluate the anti-secretory and the anti-ulcerogenic activities of the churna and to compare its activity with that of ranitidine in a pyloric ligated model of rats.
Material and methods: Four groups of rats with 6 animals in each served as the ulcer controls, churna low dose (500 mg/kg), churna high dose (750mg/kg) and ranitidine (25mg/kg). The control group rats received only vehicle (2% (v/v) gum acacia), while the rats of the other groups received the respective dose of the churna or ranitidine which was suspended in the vehicle. The treatments were given twice a day, orally, for two days. After 1 hour of the last dose, pyloric ligations were performed and the rats were sacrificed for evaluation after four hours of the ligations. The gastric contents were collected and its volume, pH and acidity were measured. The numbers of ulcers and their lengths were measured which were used to calculate the gastric irritancy index and the curative ratio. The histological examinations of the gastric tissues were also performed.
Results: The churna, in both doses, significantly decreased the volumes of the gastric contents, the ulcer score, the length of the ulcer, the gastric irritancy index and pH increased as compared to those in the control group. The effects of the churna were comparable to that of ranitidine. The histopathological evaluation of the gastric tissue also supported the results.
Conclusion: Avipattikar churna has anti-secretory and anti-ulcerogenic effects which are comparable to those of ranitidine in peptic ulcer diseases.
PMCID: PMC3708215  PMID: 23905120
Avipattikar churna; Gastric acid; Peptic ulcer; Pyloric ligation; Ranitidine, Rats
14.  Clinical efficacy of Bhringarajasava as Naimittika Rasayana in Rajayakshma with special reference to pulmonary tuberculosis 
Ayu  2012;33(4):523-529.
The clinical study was conducted at the Out Patient Department of State TB Training and Demonstration Centre, S.R. Nagar, Hyderabad, Andhra Pradesh, India, during June 2003 to December 2004. A group of 60 patients of PTB were included in the study and were divided into two equal groups. Both the groups were on the Directly Observed Treatment Short – course chemotherapy (DOTS) regime. The test group was given DOTS + Bhringarajasava (30 ml thrice a day) and the control group was only on DOTS. The study was to evaluate whether the addition of Bhringarajasava as Naimittika Rasayana (complementary drug) is beneficial in providing faster and better relief or not. Both subjective and objective parameters were considered for the assessment of results. Among the specific symptomatology, Amsaparsabitapah (pain in costal and scapular region), Kasa (cough), Jwara (pyrexia), Swasa (dyspnoea) and Bhaktadwesha (anorexia) were the symptoms manifested by all the patients. Results of the present study indicate that better, safer, and faster relief provided by the addition of Bhringarajasava to DOTS. This is an effort to utilize drugs from the vast Ayurvedic pharmacopoeia as safe adjuvant to DOTS regime so that toxicity and associated side effects of the DOTS can be ameliorated. This process of using therapies from two disparate systems of medicine could potentially lead to further enhancements in the field of complementary medicine and create a symbiosis between the different systems, which may lead to Rasayana DOTS (R-DOTS) in future.
PMCID: PMC3665204  PMID: 23723670
Ayurveda; Bhringarajasava; pulmonary tuberculosis; Rajayakshma; Rasayana
15.  Toxicological study of Balacaturbhadrika churna 
Balacaturbhadrika churna has an important place in pediatric practice in Ayurveda. Millennia of use of this formulation bears testimony to its safety when used for prolonged duration in children. This prompted us to initiate a long-term, acute oral toxicity evaluation of Balacaturbhadrika churna in rats. The study was carried out by administering Balacaturbhadrika churna orally once only in a dose up to 2000 mg/kg. For long-term toxicity, Balacaturbhadrika churna was administered in doses of 450 and 900 mg/kg orally for 45 consecutive days. The effects of the drug on ponderal changes, hematological, biochemical and histological parameters were noted. The acute toxicity experiment showed that the drug did not produce any signs and symptoms of toxicity (or mortality) up to the dose of 2000 mg/kg. Long-term toxicity results showed that, even at higher dose of 900 mg/kg, Balacaturbhadrika churna did not affect the parameters studied, to a significant extent. The doses employed for these toxicity studies were several times higher than normal clinical doses of Balacaturbhadrika churna, hence the observed changes will probably not become apparent at therapeutic dose level.
PMCID: PMC3131776  PMID: 21760693
Aconitum heterophyllum; acute toxicity; Balacaturbhadrika churna; long-term toxicity
16.  A Comparative clinical trial on the role of Panchakarma therapy and Unmada Gajankusha Rasa in the cases of major depressive disorder vis-à-vis kaphaja Unmada 
Ayu  2010;31(2):205-209.
Depression is a common but serious mood disorder which exerts wide range of physical, physiological and psychological impact. On the basis of the severity of disease, depression is classified under various categories. Of all the types of depression, major depressive disorder resembles the features of kaphaja Unmada. The patients of Kaphaja Unmada are dirty in appearance, their speech and activities are retarded and they prefer to remain in solitude and lonely places. The presentstudy has been conducted in eighty patients of major depressive disorder dividing them into four groups, A, B, C and D using Vamana therapy and Unmada Gajankusha Rasa in the dose of 250 mg twice daily with water. The results were assessed on scoring of clinical symptoms and signs and by using Hamilton depression rating scale (HDRS).The results reveal the mild to moderate degree of response over various parameters which has been presented in detail in the article.
PMCID: PMC3215365  PMID: 22131711
Kaphaja Unmada; major depressive disorder ; Panchakarma; Unmada Gajankusha Rasa Vamana karma
17.  Antibacterial activity of some Indian Ayurvedic preparations against enteric bacterial pathogens 
In Ayurveda, various herbal preparations are clinically used to prevent or cure infectious diseases. Herbal preparations such as Triphala churna, Hareetaki churna, Dashmula churna, Manjistadi churna, Sukhsarak churna, Ajmodadi churna, Shivkshar pachan churna, Mahasudarshan churna, Swadist Virechan churna and Pipramool churna were investigated by preparing their organic solvent extract for antibacterial potential against enteric bacterial pathogens such as Escherichia coli, Staphylococcus aureus, Enterobacter aerogenes, Pseudomonas aeruginosa, Bacillus subtilis, Klebsiella pneumoniae, Salmonella typhi, Staphylococcus epidermidis, Salmonella typhimurium and Proteus vulgaris, respectively. In the present study, Triphala churna, Hareetaki churna, Dashmula churna were potent antibacterial agents against S. epidermidis, P. vulgaris, S. aureus, E. coli, P. aeruginosa and S. typhi. The study supports the use of these herbal preparations not only as dietary supplements but also as agents to prevent or control enteric bacterial infections.
PMCID: PMC3217688  PMID: 22171288
Antibacterial activity; dashmula churna; hareetaki churna; triphala churna
18.  Process Standardization of Rasamanikya 
Ayu  2010;31(1):7-11.
Rasamanikya is a famous drug, frequently used by Ayurvedic physicians for Vata-Kaphaja diseases like Shwasa, Kasa and Kushtha (Skin disorders). Various methods of preparation have been found described in Rasa classics. Generally it is prepared by Shuddha Haratala which is kept between two thin transparent Abharaka Patra (mica sheets) in small scale and in sharava for large scale, heated up to desired level. There are so many methods and different liquid media have been found described for Shodhana of Haratala. Therefore the methods of preparation of Rasamanikya and Shodhana process of Haratala have been validated through various experiments. Tankana-treated Haratala (T. Treated) is found best for Shodhana process and final product too i.e. Rasamanikya in terms of pharmaceutical standards i.e. Ruby in colour, along with reproducibility of fixed quality.
PMCID: PMC3215326  PMID: 22131676
Shodhana; Validation; T-Treated Haratala
19.  A clinical study on Adhimantha and it's management with Nayanamrita Lauha and Triphaladi Varti 
Ayu  2010;31(1):62-66.
Adhimantha is a disease which has been mentioned by Sushruta as an intense feeling of the eye, wherein eye seems to be being extracted out and churned up alongwith the involvement of the half of the head in association with specific features of the particular Dosha involved. Glaucoma is a disease which is characterized by raised intra-ocular pressure, optic disc cupping and visual field defect. The clinical study was done on 79 patients of Kaphaja Adhimantha in 4 different groups. Group A was treated with Triphaladi Varti. Group B was treated with Nayanamrita Lauha. Group C was combined group wherein both Nayanamrita Lauha and Triphaladi Varti were given. Group D was treated with placebo eye drop (Saurastra Netra Bindu). After the enrolment of the patients for this study, signs and symptoms such as dimness of vision, heaviness in head, coloured haloes, optic disc changes, IOP and visual field changes were studied before, during and after the treatment. The study indicates that combined group showed better results as compared to other groups.
PMCID: PMC3215324  PMID: 22131687
Adhimantha; Glaucoma; Nayanamrita Lauha; Triphaladi Varti
20.  Efficacy of Sri Lankan Traditional Decoction of Katuwelbatu Deduru Katukadi in treatment of Kaphaja Shira Shula (Chronic Sinusitis) 
Ayu  2010;31(1):58-61.
Kaphaja Shira Shula is one of the Shiro Roga. Chronic sinusitis is inflammation of the sinuses behind the forehead, cheeks, and eyes, which continues for a long time or keeps recurring. Kaphaja Shira Shula can be correlated with Chronic Sinusitis. The decoction of Katuwelbatu Deduru Katuka is mentioned in Watika Prakaranaya, a book on Sri Lankan Traditional Medicine. The ingredients of this decoction are Solanum xanthocarpum, Cuminum cyminum, Nigella sativa, Picroihiza kurrota and Clerodendrum serratum. But in this study Saussurea lappa is used instead of C. serratum with the experience of traditional physician, Weerasinghe. Aim of this study was to scientifically evaluate the efficacy of this decoction in Kaphaja Shira Shula. Eighty patients suffering from Chronic sinusitis were selected from Ayurveda Teaching Hospital, Borella, Sri Lanka and randomly divided into two groups. X-ray of Para nasal sinuses and total white cell count before treatment and after treatment were recorded. Group one was treated with 120 ml of decoction of Katuwelbatu Deduru Katuka and Group two with 120 ml of placebo twice a day for twenty one days. Partial and complete symptomatic relief and reduction in esinophil count in the blood were observed in the treated group. It is observed that decoction of Katuwelbatu Deduru Katukadiya can be used in treatment of Kaphaja Shira Shula (Chronic sinusitis) effectively.
PMCID: PMC3215323  PMID: 22131686
Decoction of Katuwelbatu Deduru Katukadiya; Kaphaja Shira Shula; Chronic Sinusitis
21.  A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz.] 
Ayu  2012;33(3):447-449.
Haritaki is praised as the best salutary drug which can be used in almost all ages of human life and is reputed for its Anulomana property. In Ayurveda, it has been mentioned that fruits of Haritaki when used in different forms give different type of actions. As the prime therapeutic utility of Haritaki is Anulomana, in the present study, two dosage forms of Haritaki fruits namely Churna and Vati were evaluated for intestinal transit time to evaluate its effect in two different dosage forms. Mature fruits were collected, authenticated, and processed as per classics to get Churna and Vati. Test drugs were administered in the dose of 550 mg/kg and evaluation on intestinal transit time was carried out by adopting kaolin expulsion test in mice. The results show that both the dosage forms of Haritaki significantly shortened intestinal transit time and between them Churna form is found to be better.
PMCID: PMC3665098  PMID: 23723658
Anulomana; Churna; Haritaki; intestinal transit; kaolin; Terminalia Chebula; Vati
22.  PA01.25. Clinical evaluation of chitrakadi churna and kshar basti in the management of amavata with special reference to rheumatoid arthritis 
Ancient Science of Life  2012;32(Suppl 1):S75.
The disease Amavata can be presented as very similar to Rheumatoid Arthritis. Rheumatoid Arthritis is chronic in nature and affects mostly middle aged people. For this disease there is no satisfactory medicine is available till date. But in Ayurveda there are many drugs described for Amavata which are cost effective and easily available with no side effects. The present clinical study evaluated the effect of Chitrakadi Churna and Kshar Basti in the management of Amavata.
30 clinically diagnosed patient of Amavata were registered and completed the trial. In this 15 patients (Group A) administered Chitrakadi Churna 4gm twice daily with lukewarm water after meal. Another 15 patients (Group B) administered Chitrakadi Churna 4gm twice daily with lukewarm water after meal and Kshar Basti as per Kalbasti krama i.e 16days followed by local Snehan Swedan.
Results of this trial were encouraging as there is improvement in each symptom of patient like pain, stiffness, swelling, and tenderness. Group A in which only Chitrakadi Churna was administered there was no significant improvement seen statistically. But Group B in which Chitrakadi Churna as well as Kshar Basti was administered highly significant improvement seen statistically. Details of the Statistical test and other important will be discussed at the time of paper presentation.
From present clinical trial it is concluded that this therapy is very useful for pain, swelling, tenderness and stiffness, which were chief complaint of the patient. Chronicity more than 3 years did not show marked improvement. And also this drug is supposed to be very good combination of Vedanashamaka, Shothaghna, Amapachaka Dravyas. No untoward effects were seen except mild loss of weight.
PMCID: PMC3800956
23.  Mast cell stabilization potential of Sitopaladi churna: An ayurvedic formulation 
Pharmacognosy Research  2013;5(4):306-308.
Sitopaladi churna (SPC) is a popular polyherbal ayurvedic formulation used in the treatment of allergy and respiratory diseases.
The present study was aimed to justify the classical use of antiallergic claim by performing the mast cell stabilizing activity of extracts of SPC.
Materials and Methods:
The protective effect of aqueous extract and methanolic extract - of SPC against compound 48/80-induced mast cell degranulation model was carried out.
Sitopaladi churna aqueous extract (SPCA) at the dose of 300 mg/kg and Sitopaladi churna methanolic extract (SPCM) at the doses of 150 and 300 mg/kg showed better protection of mast cell degranulation (65%-74%) and were comparable to the standard drug ketotifen (79%), when peritoneal mast cells were treated with compound 48/80. The protection against mast cell degranulation was significant (P < 0.0001).
From the above results, it has been justified that SPC can be used to treat allergic disorders.
PMCID: PMC3807997  PMID: 24174826
Compound 48/80; mast cell stabilizing; Sitopaladi churna
24.  A Comparative Study of the effect of Vasa Avaleha prepared with Vasa Swarasa and Vasa Kwatha in Tamaka Shwasa 
Ancient Science of Life  2009;28(3):23-28.
Vasa (Adhatoda vasica) is used to treat the diseases such as Shwasa, Kasa and Raktapitta in different dosage forms like Swarasa, Avaleha and Ghrita. Although the Avaleha Kalpana is not available in Brihattraya, but Gada Nigraha by Aacharya Sodhal and Bhava Prakasha have described its use in the form of Avaleha to treat the diseases of Respiratory System.
The objective of this study is to compare the efficacy of two types of Vasa Avaleha prepared with either ‘Swarasa’ or ‘Kwatha’ of Vasa during their preparation. The outcomes were assessed on the basis of relief in subjective symptoms and certain hematologicalparameters.
Total 35 patients were enrolled for the study. Both the groups showed highly significant results on cardinal symptoms like frequency, intensity and duration of Shwasa (dyspnoea), Kasa (coughing), Peenasa (rhinitis) with maximum percentage in Vasa Avaleha (Swarasa). The formulations also shows a insignificant decrease in haematocrit values which includes Neutrophil, Eosinophil, Lymphocyte count and TL.STL. Overall Vasa Avaleha (Swarasa) shows maximum percentage of improvement than the other group.
PMCID: PMC3336325  PMID: 22557317
25.  Mootrala Karma of Kusha [Imperata cylindrica Beauv.] and Darbha [Desmostachya bipinnata Stapf.] - A comparative study 
Ayu  2012;33(3):387-390.
Kusha (Imperata cylindrica Beauv.) and Darbha (Desmostachya bipinnata Stapf.) are enlisted among Trinapanchamoola, which is a well-known diuretic and are individually enumerated in the Mootravirechaneeya Dashemani. The article deals with the evaluation and comparison of the individual Mootrala (diuretic) action of the two drugs in healthy volunteers. In this study, 29 healthy volunteers were divided into three groups administered with Darbha Moola Churna, Kusha Moola Churna, and placebo in each group for 14 days. The volunteers were subjected to evaluation of diuretic activity by maintaining the daily total input–output charts during the course of the study. The volunteers were advised to consume a minimum 2 l of water daily. Results show that Darbha and Kusha leaded to a percentage increase in urine volume as compared to placebo group, but the result was statistically insignificant.
PMCID: PMC3665103  PMID: 23723646
Darbha; Desmostachya bipinnata; diuretic; Imperata cylindrica; Kusha; Mootrala

Results 1-25 (1036248)